Search

國際臍帶血庫(CO.US)Q4淨利潤同比增長31.7%,新增用戶數同比增長4.8% 作者智通財經 - Investing.com

raos.prelol.com
國際臍帶血庫(CO.US)Q4淨利潤同比增長31.7%,新增用戶數同比增長4.8% © Reuters. 國際臍帶血庫(CO.US)Q4淨利潤同比增長31.7%,新增用戶數同比增長4.8%

智通財經APP獲悉,6月29日美股盤後,國際臍帶血庫(CO.US)公布了2021財年第四季度及全年未經審計財務業績。數據顯示,該公司Q4營收3.02億元(人民幣,下同),上年同期3.00億元,同比增長0.8%。歸屬于公司股東淨利潤1.28億元,上年同期爲9700.7萬元,同比增長31.7%。

基本和攤薄後每股收益爲1.05元,上年同期爲0.80元。

毛利潤爲2.56億元。毛利率爲84.8%。

運營利潤同比下降0.7%,至1.48億元。運營利潤率爲49.0%,上年同期爲49.8%。non-GAAP運營利潤同比下降0.8%至1.60億元。

經營活動産生的淨現金同比增長134.6%至2.11億元。

季度內,新增用戶數爲19367人,同比增長4.8%;累計用戶數達901437人。

全年業績方面,該公司營收爲11.60億元,同比下降5.1%。

基本和攤薄後每股收益爲4.18元,上年同期爲3.87元。

毛利潤爲9.81億元,同比下降5.0%。

運營利潤同比下降2.5%至5.45億元;non-GAAP運營利潤同比下降2.4%至5.94億元。

歸屬于公司股東淨利潤爲5.08億元,同比增長8.0%。

經營活動産生的淨現金同比增長1.1%至6.31億元。

全年新增用戶數爲72045人,同比下降14.5%。

免責聲明: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Adblock test (Why?)



"利潤" - Google 新聞
June 29, 2021 at 06:17AM
https://ift.tt/3qC4Rt5

國際臍帶血庫(CO.US)Q4淨利潤同比增長31.7%,新增用戶數同比增長4.8% 作者智通財經 - Investing.com
"利潤" - Google 新聞
https://ift.tt/38PcTEm
Mesir News Info
Israel News info
Taiwan News Info
Vietnam News and Info
Japan News and Info Update
https://ift.tt/35B1JmQ

Bagikan Berita Ini

0 Response to "國際臍帶血庫(CO.US)Q4淨利潤同比增長31.7%,新增用戶數同比增長4.8% 作者智通財經 - Investing.com"

Post a Comment

Powered by Blogger.